Trial intelligence / Profile preview

Caudal Bupivacaine vs IV Morphine for Pediatric Post-Op Pain (CaBuMorph)

NCT02456142Phase 4Completed

Sponsor
Makerere University
Start
Jul 2015
Primary completion
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Makerere University. Started Jul 2015; status: completed.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02456142.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02456142.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call